Apyx Medical Corp. (NASDAQ: APYX) reported Q1 EPS of ($0.06), $0.19 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.2 million.

Fiscal Year 2020 Financial Outlook:

Given the challenges and uncertainties posed by the ongoing global pandemic, the Company will not be providing full year 2020 financial guidance at this time. Assuming a more normalized business environment prevails at the time of our second quarter results conference call in August, we plan to provide updated expectations at that time.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.